Bionano Genomics, Inc. (BNGO)
USD 4.08
(2.0%)
USD 4.08
(2.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -215.24 Million USD | -5.87% |
| 2022 | -131.69 Million USD | -70.81% |
| 2021 | -77.1 Million USD | -100.0% |
| 2020 | -38.55 Million USD | -48.99% |
| 2019 | -25.87 Million USD | -26.74% |
| 2018 | -20.41 Million USD | 12.08% |
| 2017 | -23.21 Million USD | -9.69% |
| 2016 | -21.16 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -20.27 Million USD | 37.27% |
| 2024 Q1 | -27.13 Million USD | -35.42% |
| 2023 Q3 | -113.21 Million USD | -188.53% |
| 2023 FY | -139.42 Million USD | -5.87% |
| 2023 Q4 | -20.03 Million USD | 82.3% |
| 2023 Q1 | -37.84 Million USD | -0.84% |
| 2023 Q2 | -39.23 Million USD | -3.69% |
| 2022 Q4 | -37.52 Million USD | -16.73% |
| 2022 Q1 | -29.94 Million USD | -4.03% |
| 2022 Q3 | -32.14 Million USD | -0.22% |
| 2022 FY | -131.69 Million USD | -70.81% |
| 2022 Q2 | -32.07 Million USD | -7.13% |
| 2021 Q3 | -20.67 Million USD | -25.5% |
| 2021 Q4 | -28.78 Million USD | -39.2% |
| 2021 FY | -77.1 Million USD | -100.0% |
| 2021 Q1 | -11.16 Million USD | -0.32% |
| 2021 Q2 | -16.47 Million USD | -47.59% |
| 2020 FY | -38.55 Million USD | -48.99% |
| 2020 Q1 | -9.76 Million USD | -36.33% |
| 2020 Q2 | -7.43 Million USD | 23.84% |
| 2020 Q3 | -10.22 Million USD | -37.55% |
| 2020 Q4 | -11.12 Million USD | -8.81% |
| 2019 FY | -25.87 Million USD | -26.74% |
| 2019 Q4 | -7.16 Million USD | -25.95% |
| 2019 Q3 | -5.68 Million USD | 16.94% |
| 2019 Q2 | -6.84 Million USD | -10.66% |
| 2019 Q1 | -6.18 Million USD | -1.42% |
| 2018 Q1 | -4.33 Million USD | 17.25% |
| 2018 Q2 | -4.01 Million USD | 7.46% |
| 2018 FY | -20.41 Million USD | 12.08% |
| 2018 Q3 | -5.96 Million USD | -48.77% |
| 2018 Q4 | -6.09 Million USD | -2.17% |
| 2017 FY | -23.21 Million USD | -9.69% |
| 2017 Q1 | -6.18 Million USD | 0.0% |
| 2017 Q2 | -6.76 Million USD | -9.25% |
| 2017 Q3 | -5.03 Million USD | 25.58% |
| 2017 Q4 | -5.23 Million USD | -4.14% |
| 2016 FY | -21.16 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -97.35 Million USD | -121.088% |
| Applied DNA Sciences, Inc. | -10.95 Million USD | -1865.117% |
| Aspira Women's Health Inc. | -18.85 Million USD | -1041.762% |
| Biodesix, Inc. | -41.34 Million USD | -420.645% |
| BioNexus Gene Lab Corp. | -2.59 Million USD | -8199.121% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -2599.597% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -2599.597% |
| CareDx, Inc | -101.9 Million USD | -111.232% |
| Check-Cap Ltd. | -19.28 Million USD | -1016.011% |
| Castle Biosciences, Inc. | -67.97 Million USD | -216.644% |
| DarioHealth Corp. | -56.18 Million USD | -283.073% |
| Exact Sciences Corporation | -215.01 Million USD | -0.108% |
| Fulgent Genetics, Inc. | -72.69 Million USD | -196.093% |
| Guardant Health, Inc. | -564.72 Million USD | 61.885% |
| ICON Public Limited Company | 956.15 Million USD | 122.512% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 119.619% |
| Illumina, Inc. | -1.06 Billion USD | 79.865% |
| Intelligent Bio Solutions Inc. | -10.28 Million USD | -1993.177% |
| iSpecimen Inc. | -11.16 Million USD | -1827.104% |
| Standard BioTools Inc. | -76.6 Million USD | -180.999% |
| MDxHealth SA | -27.32 Million USD | -687.664% |
| 23andMe Holding Co. | -321.35 Million USD | 33.02% |
| Medpace Holdings, Inc. | 336.82 Million USD | 163.904% |
| Myriad Genetics, Inc. | -123.7 Million USD | -74.006% |
| Mainz Biomed B.V. | -26.64 Million USD | -707.835% |
| ENDRA Life Sciences Inc. | -10.52 Million USD | -1945.912% |
| NeoGenomics, Inc. | -107.73 Million USD | -99.789% |
| Neogen Corporation | 58.66 Million USD | 466.918% |
| Inotiv, Inc. | -81.46 Million USD | -164.234% |
| Natera, Inc. | -446.24 Million USD | 51.765% |
| OpGen, Inc. | -15.68 Million USD | -1271.994% |
| OPKO Health, Inc. | -157.02 Million USD | -37.08% |
| Psychemedics Corporation | -2.92 Million USD | -7268.881% |
| Prenetics Global Limited | -52.51 Million USD | -309.885% |
| Prenetics Global Limited | -52.51 Million USD | -309.885% |
| Precipio, Inc. | -7.62 Million USD | -2724.738% |
| Personalis, Inc. | -109.93 Million USD | -95.791% |
| RadNet, Inc. | 98.69 Million USD | 318.087% |
| Sera Prognostics, Inc. | -39.82 Million USD | -440.531% |
| Sotera Health Company | 276.69 Million USD | 177.792% |
| Neuronetics, Inc. | -30.55 Million USD | -604.474% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -4852.715% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -4852.715% |
| Trinity Biotech plc | -27.04 Million USD | -695.877% |
| T2 Biosystems, Inc. | -49.66 Million USD | -333.402% |
| Twist Bioscience Corporation | -220.83 Million USD | 2.53% |
| Exagen Inc. | -22.83 Million USD | -842.527% |